Circulating endothelial cells in patients with chronic lymphocytic leukemia

Annals of Hematology

Volumn 87, Issue 5, 2008, Pages 369-373

  Go, Ronald S ^a   Jobe, Dean A ^a   Asp, Krista E ^a   Callister, Steven M ^a   Mathiason, Michelle A ^a   Meyer, Lori A ^a   Bottner, Wayne A ^a   Cole, Craig E ^a   Farnen, John P ^a   Frisby, Kathleen A ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; B cell; Chronic; Circulating; Endothelial; Leukemia; Thrombospondin

Indexed keywords

ANTINEOPLASTIC AGENT; CD146 ANTIGEN; CD31 ANTIGEN; CD45 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; THROMBOSPONDIN 1; VASCULOTROPIN;

ADULT; AGED; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STAINING; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; ANTIGENS, CD146; ANTIGENS, CD31; ANTIGENS, CD45; APOPTOSIS; CASE-CONTROL STUDIES; ENDOTHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; HUMANS; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOSPONDIN 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41549153032     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0435-y     Document Type: Article

References (23)

1. Kini AR, Kay NE, Peterson LC (2000) Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 14:1414-1418
2. Chen H, Treweeke AT, West DC, Till KJ, Cawley JC, Zuzel M et al (2000) In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells. Blood 96:3181-3187
3. Molica S, Vacca A, Ribatti D, Cuneo A, Cavazzini F, Levato D et al (2002) Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 100:3344-3351
4. Bairey O, Boycov O, Kaganovsky E, Zimra Y, Shaklai M, Rabizadeh E (2004) All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells. Leuk Res 28:243-248
5. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM et al (2005) Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 93:228-235
6. Bertolini F, Shaked Y, Mancuso P, Kerbel RS (2006) The multifaceted circulating endothelial cell in cancer: Towards marker and target identification. Nat Rev Cancer 11:835-845
7. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F (2001) Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97:3658-3661
8. Zhang H, Vakil V, Braunstein M, Smith EL, Maroney J, Chen L et al (2005) Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 105:3286-3294
9. Wierzbowska A, Robak T, Krawczynska A, Wrzesien-Kus A, Pluta A, Cebula B et al (2005) Circulating endothelial cells in patients with acute myeloid leukemia. Eur J Haematol 75:492-497
10. Mancuso P, Colleoni M, Calleri A, Orlando L, Maisonneuve P, Pruneri G et al (2006) Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood 108:452-459
11. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP (1997) Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337:1584-1590
12. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F (1999) Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 93:2951-2958
13. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS (2005) Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 67:1078-1083
14. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S et al (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 87:4990-4997
15. Shanafelt TD, Kay NE (2006) The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Semin Oncol 33:174-185
16. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D et al (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 96:2240-2245
17. Gora-Tybor J, Blonski JZ, Robak T (2003) Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia. Mediators Inflamm 12:167-171
18. Molica S, Vitelli G, Levato D, Giannarelli D, Vacca A, Cuneo A et al (2004) Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression. Eur J Haematol 73:36-42
19. Go RS, Horstman AL (2002) Circulating basic fibroblast growth factor and vascular endothelial growth factor levels in cancer patients: implications for anti-angiogenic therapy. Proc Am Soc Clin Oncol 21:3031 abstr
20. Shanafelt TD, Geyer S, Bone N, Schwager S, Lee YK, Nowakowski G, et al (2005). Evaluation of the Prognostic Implications of Pro- and Anti-Angiogenic Cytokines in 311 Patients with Untreated Chronic Lymphocytic Leukemia. Blood 106:712 abstr
21. Molica S, Vitelli G, Levato D, Ricciotti A, Digiesi G (2002) Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblast growth factor in early B-cell chronic lymphocytic leukaemia. Br J Cancer 86:31-35
22. Clinical trials. National Cancer Institute. Available at: http://www.nci.nih.gov/search/clinical_trials. Accessed August 6, 2007
23. Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, Tong RT et al (2005) Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal cancer patients. J Clin Oncol 23:8136-8139